Clinical Trials in Poland: Statistics of the First Half of 2018
Clinical Trials in Poland: Statistics of the First Half of 2018 Cromos™ Pharma continues with a series of briefs devoted to the clinical trials’ statistics in the geographies of its clinical operations. This brief is focused on Poland and the trials conducted there in the first half of 2018. The data presented in the article is based on the information from ClinicalTrials.gov. Please follow this link to
Cromos Pharma begins operations in Kazakhstan
Cromos Pharma begins operations in Kazakhstan Cromos™ Pharma, a premier full service regional contract research organization (CRO) announced that it has begun operations in Kazakhstan. The company has initiated three phase III trials in the region with the fourth study nearing finalization of the prelaunch phase. “Kazakhstan is an uncharted territory for most clinical trial organizations and as such it epitomizes
cromos-pharma-at-the-swiss-biotech-day-in-basel-on-4-may-2017
cromos-pharma-at-the-swiss-biotech-day-in-basel-on-4-may-2017 Meet Cromos™ Pharma’s VP, International Business & Operations, Dr. Gearóid Tuohy in Basel at the Swiss Biotech Day on 4 May and find out how Cromos™ Pharma can assist you in your clinical drug development programmes. The Swiss Biotech Day is the leading biotechnology conference in Switzerland. This event will bring together more than 500

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us